Nasrat Hakim - Elite Pharma Chairman of The Board, CEO and Pres
| ELTPDelisted Stock | USD 0.04 0 6.75% |
Chairman
Mr. Nasrat Hakim was appointed as Chairman of the Board, President, Chief Executive Officer of the Company. Mr. Hakim has more than 30 years of pharmaceutical and medical industry experience in Quality Assurance, Analytical Research and Development, Technical Services and Regulatory Compliance. He brings with him proven management experience, indepth knowledge of manufacturing systems, development knowledge in immediate and extended release formulations and extensive regulatory experience of GMP and FDA regulations. From 2004 2013, Mr. Hakim was employed by Actavis, Watson and Alpharma in various senior management positions. Most recently, Mr. Hakim served as International Vice President of Quality Assurance at Actavis, overseeing 25 sites with more than 3, 000 employees under his leadership. Mr. Hakim also served as Corporationrationrate Vice President of Technical Services, Quality and Regulatory Compliance for Actavis U.S., Global Vice President, Quality and Regulatory Compliance for Alpharma, as well as Executive Director of Quality Unit at TheraTech, overseeing manufacturing and research and development. In 2009, Mr. Hakim founded Mikah Pharma, LLC, a virtual, fully functional pharmaceutical company. Mr. Hakim holds a Bachelor in ChemistryBioChemistry and Masters of Science in Chemistry from California State University at Sacramento, Sacramento, CA a Masters in Law with Graduate Certification in U.S. and International Taxation from St. Thomas University, School of Law, Miami, FL. and a Graduate Certification in Regulatory Affairs from California State University at San Diego, San Diego, CA since 2016.
| Age | 62 |
| Tenure | 8 years |
| Phone | 201 750 2646 |
| Web | https://www.elitepharma.com |
Elite Pharma Management Efficiency
The company has return on total asset (ROA) of 0.0739 % which means that it generated a profit of $0.0739 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.274 %, meaning that it created $0.274 on every $100 dollars invested by stockholders. Elite Pharma's management efficiency ratios could be used to measure how well Elite Pharma manages its routine affairs as well as how well it operates its assets and liabilities.Elite Pharma currently holds 1.39 M in liabilities with Debt to Equity (D/E) ratio of 0.57, which is about average as compared to similar companies. Elite Pharma has a current ratio of 4.41, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Elite Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Elite Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Elite Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Elite to invest in growth at high rates of return. When we think about Elite Pharma's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 1 records | CHAIRMAN Age | ||
| Horst Zerbe | Intelgenx Technologs | 76 | |
Management Performance
| Return On Equity | 0.27 | ||||
| Return On Asset | 0.0739 |
Elite Pharma Leadership Team
Elected by the shareholders, the Elite Pharma's board of directors comprises two types of representatives: Elite Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Elite. The board's role is to monitor Elite Pharma's management team and ensure that shareholders' interests are well served. Elite Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Elite Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Douglas Plassche, Executive VP of Operations | ||
| Sophy Abraham, Head Affairs | ||
| Robert Chen, S CFO | ||
| JD MBA, VP Legal | ||
| Nasrat Hakim, Chairman of The Board, CEO and Pres | ||
| Dianne Will, VP of Investor Relations and Corporate Affairs | ||
| Kirko Kirkov, Chief Officer |
Elite Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Elite Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.27 | ||||
| Return On Asset | 0.0739 | ||||
| Profit Margin | 0.20 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 27.92 M | ||||
| Shares Outstanding | 1.01 B | ||||
| Shares Owned By Insiders | 17.53 % | ||||
| Shares Owned By Institutions | 0.06 % | ||||
| Number Of Shares Shorted | 757.07 K | ||||
| Price To Earning | 5.21 X |
Pair Trading with Elite Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Elite Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elite Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against Elite OTC Stock
| 0.68 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.67 | DYNT | Dynatronics | PairCorr |
| 0.63 | SXTC | China SXT Pharmaceuticals | PairCorr |
| 0.62 | BIOA | BioAge Labs, | PairCorr |
| 0.58 | BGXX | Bright Green Corp | PairCorr |
The ability to find closely correlated positions to Elite Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Elite Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Elite Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Elite Pharma to buy it.
The correlation of Elite Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Elite Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Elite Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Elite Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Elite OTC Stock
If you are still planning to invest in Elite Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Elite Pharma's history and understand the potential risks before investing.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |